00088-1206 Anzemet - CanMED: NDC

Product NDC:

00088-1206

Brand Name:

Anzemet

Generic Name:

Dolasetron mesylate

Dosage Form Name:

Injection

Administration Route:

Intravenous

Substances:

Name: Dolasetron mesylate

Strength: 100.0

Unit: mg/5mL

Packages:

Code: 00088-1206-32

Description: 5 mL in 1 VIAL, SINGLE-USE (0088-1206-32)

Effective Date: Sept. 11, 1997

Discontinued: Sept. 30, 2017

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

No Longer Used

CanMED and the Oncology Toolbox